These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21918443)

  • 1. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis.
    Schmidt J; Pulido JS; Matteson EL
    Curr Opin Ophthalmol; 2011 Nov; 22(6):489-95. PubMed ID: 21918443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study.
    Ungprasert P; Crowson CS; Cartin-Ceba R; Garrity JA; Smith WM; Specks U; Matteson EL; Makol A
    Rheumatology (Oxford); 2017 Oct; 56(10):1763-1770. PubMed ID: 28957561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-ANCA Vasculitis Presenting with Orbital Infiltration.
    Yoo KG; Abella-Ayala F; Lerner A; Kwok A; Chang JR
    Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):e74-e77. PubMed ID: 38231652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Trials in Vasculitis.
    Gopaluni S; Jayne D
    Curr Treatm Opt Rheumatol; 2016; 2(2):161-177. PubMed ID: 28936387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis.
    Sayer M; Chapman GB; Thomas M; Dhaun N
    Curr Rheumatol Rep; 2024 Jan; 26(1):12-23. PubMed ID: 38015334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinuclear Antineutrophil Cytoplasmic Antibody-Associated Ocular Manifestations: Case Series and Literature Review.
    Lim YW; Liew OH
    Ocul Immunol Inflamm; 2024 May; ():1-4. PubMed ID: 38709232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-associated vasculitis presenting with isolated neurological manifestations in a patient with cocaine abuse: a case report and literature review.
    Aseem F; Lin V; Gilbert AL; Rivadeneira AC; Jennette JC; Bouldin TW; Khoshbakht F; Lee YZ; Chamberlin K; Gelinne A; Mehrabyan AC; Javed B; Dujmovic Basuroski I; Diaz MM
    Clin Rheumatol; 2024 Apr; 43(4):1401-1407. PubMed ID: 38416306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eye in systemic vasculitis.
    Menezo V; Lightman S
    Clin Med (Lond); 2004; 4(3):250-4. PubMed ID: 15244360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment goals in ANCA-associated vasculitis: defining success in a new era.
    Alberici F; Tedesco M; Popov T; Balcells-Oliver M; Mescia F
    Front Immunol; 2024; 15():1409129. PubMed ID: 38938575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on antineutrophil cytoplasmic autoantibody vasculitis in children.
    Bloom JL; Wu EY
    Curr Opin Rheumatol; 2024 Jul; ():. PubMed ID: 38990100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.
    Karaca I; Tran EM; Park S; Bromeo A; Khojasteh H; Tran ANT; Yavari N; Akhavanrezayat A; Yasar C; Uludag Kirimli G; Than NTT; Hassan M; Or C; Ghoraba H; Do DV; Nguyen QD
    J Ophthalmic Inflamm Infect; 2024 Mar; 14(1):12. PubMed ID: 38466527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for refractory granulomatous eye disease.
    Lower EE; Baughman RP; Kaufman AH
    Clin Ophthalmol; 2012; 6():1613-8. PubMed ID: 23055686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Involvement in Selected Rheumatic Diseases - Clinical Manifestation in Adulthood.
    Baquet-Walscheid K; Rath T; Heiligenhaus A
    Klin Monbl Augenheilkd; 2024 May; 241(5):626-632. PubMed ID: 38574680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease heterogeneity in antineutrophil cytoplasmic antibody-associated vasculitis: implications for therapeutic approaches.
    Ford JA; Monach PA
    Lancet Rheumatol; 2019 Dec; 1(4):e247-e256. PubMed ID: 38229381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis.
    Prendecki M; Pusey CD
    F1000Res; 2018; 7():. PubMed ID: 30079228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to Letter "Regarding the hypogammaglobulinemia in invasive fungal infection in ANCA -associated vasculitis.
    Baliga S; Yadav S; Sagdeo P; Balakrishnan C
    Clin Rheumatol; 2024 Jun; 43(6):2173-2174. PubMed ID: 38619725
    [No Abstract]   [Full Text] [Related]  

  • 17. Posterior Scleritis: A Case Report and Literature Review of the Management of the Condition.
    Robertson R; Ansari FA; Gafoor S; Idolor ON; Amakye D
    Cureus; 2024 Jun; 16(6):e61537. PubMed ID: 38831917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.
    Zhu K; Lv F; Hou X; Wang F; Pang L; Zhong M
    Heliyon; 2024 Jun; 10(12):e30615. PubMed ID: 38975109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleritis as the Presenting Sign of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Setting of Temporal Arteritis.
    Kuang GT; Alryalat SA; Al Deyabat O; Mortensen PW; Lee AG
    J Neuroophthalmol; 2024 Jun; ():. PubMed ID: 38863111
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.
    Marzano AV; Raimondo MG; Berti E; Meroni PL; Ingegnoli F
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):428-438. PubMed ID: 28578472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.